Back

Predicting mortality of type-2 diabetes mellitus by applying machine learning to electronic medical records in the west of scotland and hong kong

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Progress and challenges in artificial intelligence for cardiovascular risk assessment and diagnosis Artificial Intelligence ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Narinder Kaur

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Importance and limits of cardiovascular risk factors on the prediction of SCD using machine learning approach.
Professor X. Jouven (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Fully automated artificial intelligence-based cine cardiac magnetic resonance image quantification
Mr P. Mohammadi Kazaj (Bern, CH)
Abstract Slides Video
Presentation thumbnail
Preventing unnecessary echocardiograms in de novo patients referred to the cardiology outpatient clinic using electrocardiogram-based deep learning
Mr B. Arends (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Barriers and facilitators for implementation of AI algorithms for ECG analysis and triage in patients with chest pain
Mr B. Arends (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
An explainable AI for trustworthy detection of atrial fibrillation on reduced lead ECGs in mobile applications
Mr A. Hammer (Dresden, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Progress and challenges in artificial intelligence for cardiovascular risk assessment and diagnosis

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Novel support tool for predicting incident heart failure in type-2 diabetes mellitus: a precision medicine approach
thumbnail
Congress Presentation
Machine learning identifies individuals at higher risk of incident cardio-renal-metabolic diseases and cardiovascular death who have unrealised opportunities to reduce future cardiovascular risk
thumbnail
Congress Presentation
Plasma proteomics of all-cause and cause-specific mortality in individuals with and without type 2 diabetes: Results from two population-based KORA cohorts

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources